Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 2/2016

01-08-2016

Severity and outcomes according to stroke etiology in patients under 50 years of age with ischemic stroke

Authors: Daniel Prefasi, Patricia Martínez-Sánchez, Blanca Fuentes, Exuperio Díez-Tejedor

Published in: Journal of Thrombosis and Thrombolysis | Issue 2/2016

Login to get access

Abstract

To analyze the association of stroke etiological subtypes with severity and outcomes at 3 and 12 months in patients ≤50 years. Observational study of patients admitted to a stroke unit (2007–2013). Variables: demographic data, vascular risk factors, comorbidities, severity on admission (NIHSS), and good functional outcome (mRS ≤ 1) at 3 and 12 months. We used multivariate analyses to evaluate the influence of stroke etiology on severity and outcomes. We included 214 patients, 58.3 % men, mean age 41.4 years. General linear models showed all etiologies were more severe than lacunar strokes (P < 0.05). Atherothrombotic strokes showed greater severity than those of undetermined and uncommon etiology, whereas cardioembolic strokes were more severe than cryptogenic. Taking into account specific etiologies, atherothrombotic strokes (B = 5.860; 95 % CI 2.979–8.751), cervical artery dissection (CAD) [B = 7.485; 95 % confidence interval (CI) 4.734–10.237], and atrial fibrillation (AF) strokes (B = 5.773; 95 % CI 2.704–8.132) were more severe than other etiologies. Logistic regression models showed that strokes of uncommon etiology, especially those not related to CAD, had a lower probability of good outcome at 3 months [odds ratio (OR) = 0.197; CI 95 % 0.044–0.873], whereas atherothrombotic strokes were associated with this probability at 12 months (OR = 0.187; 95 % CI 0.037–0.951; P = 0.007). In patients ≤50 years of age, strokes of atherothrombotic, cardioembolic (particularly those due to AF), and uncommon etiology had a greater severity than the rest. Furthermore, strokes of uncommon etiology, especially those different from CAD, decreased the probability of a good outcome at 3 months, as did atherothrombotic strokes at 1 year.
Literature
2.
go back to reference Díez-Tejedor E, del Brutto O, Alvarez SJ, Muñoz M, Abiusi G (2001) Classification of the cerebrovascular diseases. Iberoamerican cerebrovascular diseases society. Rev Neurol 33:455–464PubMed Díez-Tejedor E, del Brutto O, Alvarez SJ, Muñoz M, Abiusi G (2001) Classification of the cerebrovascular diseases. Iberoamerican cerebrovascular diseases society. Rev Neurol 33:455–464PubMed
4.
go back to reference Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, Moran AE et al (2014) Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) and the GBD Stroke Experts Group. Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet 383:245–253CrossRefPubMedPubMedCentral Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, Moran AE et al (2014) Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) and the GBD Stroke Experts Group. Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet 383:245–253CrossRefPubMedPubMedCentral
5.
go back to reference Kissela BM, Khoury JC, Alwell K, Moomaw CJ, Adeoye O, Flaherty ML et al (2012) Age at stroke. Temporal trends in stroke incidence in large, biracial population. Neurology 79:1781–1787CrossRefPubMedPubMedCentral Kissela BM, Khoury JC, Alwell K, Moomaw CJ, Adeoye O, Flaherty ML et al (2012) Age at stroke. Temporal trends in stroke incidence in large, biracial population. Neurology 79:1781–1787CrossRefPubMedPubMedCentral
6.
go back to reference Nedeltchev K, der Maur TA, Georgiadis D, Arnold M, Caso V, Mattle HP, Schroth G et al (2005) Ischaemic stroke in young adults: predictors of outcome and recurrence. J Neurol Neurosurg Psychiatry 76:191–195CrossRefPubMedPubMedCentral Nedeltchev K, der Maur TA, Georgiadis D, Arnold M, Caso V, Mattle HP, Schroth G et al (2005) Ischaemic stroke in young adults: predictors of outcome and recurrence. J Neurol Neurosurg Psychiatry 76:191–195CrossRefPubMedPubMedCentral
7.
go back to reference Grau AJ, Weimar C, Buggle F, Heinrich A, Goertler M, Neumaier S et al (2001) Risk factors, outcome, and treatment in subtypes of ischemic stroke. The German Data Bank. Stroke 32:2559–2566CrossRefPubMed Grau AJ, Weimar C, Buggle F, Heinrich A, Goertler M, Neumaier S et al (2001) Risk factors, outcome, and treatment in subtypes of ischemic stroke. The German Data Bank. Stroke 32:2559–2566CrossRefPubMed
8.
go back to reference Pinto A, Tuttolomondo A, Di Raimondo D, Fernandez P, Licata G (2006) Risk factors profile and clinical outcome of ischemic stroke patients admitted in a Department of Internal Medicine and classified by TOAST classification. Int Angiol 25:261PubMed Pinto A, Tuttolomondo A, Di Raimondo D, Fernandez P, Licata G (2006) Risk factors profile and clinical outcome of ischemic stroke patients admitted in a Department of Internal Medicine and classified by TOAST classification. Int Angiol 25:261PubMed
9.
go back to reference Potpara TS, Lip GYH (2011) Ischemic stroke and atrial fibrillation: a deadly serious combination. Cerebrovasc Dis 32:461–462CrossRefPubMed Potpara TS, Lip GYH (2011) Ischemic stroke and atrial fibrillation: a deadly serious combination. Cerebrovasc Dis 32:461–462CrossRefPubMed
10.
go back to reference Prefasi D, Martínez-Sánchez P, Rodríguez-Sanz A, Fuentes B, Filgueiras-Rama D, Ruiz-Ares G et al (2013) Atrial fibrillation in young stroke patients:do we underestimate its prevalence? Eur J Neurol 20:1367–1374CrossRefPubMed Prefasi D, Martínez-Sánchez P, Rodríguez-Sanz A, Fuentes B, Filgueiras-Rama D, Ruiz-Ares G et al (2013) Atrial fibrillation in young stroke patients:do we underestimate its prevalence? Eur J Neurol 20:1367–1374CrossRefPubMed
11.
go back to reference Fagniez O, Tertian G, Dreyfus M, Ducreux D, Adams D, Denier C (2011) Hematological disorders related cerebral infarctions are mostly multifocal. J Neurol Sci 304:87–92CrossRefPubMed Fagniez O, Tertian G, Dreyfus M, Ducreux D, Adams D, Denier C (2011) Hematological disorders related cerebral infarctions are mostly multifocal. J Neurol Sci 304:87–92CrossRefPubMed
12.
go back to reference Martínez-Martínez M, Cazorla-García R, Rodríguez de Antonio LA, Martínez-Sánchez P, Fuentes B, Díez-Tejedor E (2010) Estados de hipercoagulabilidad e ictus isquémico en pacientes jóvenes. Neurología 25:343–348CrossRefPubMed Martínez-Martínez M, Cazorla-García R, Rodríguez de Antonio LA, Martínez-Sánchez P, Fuentes B, Díez-Tejedor E (2010) Estados de hipercoagulabilidad e ictus isquémico en pacientes jóvenes. Neurología 25:343–348CrossRefPubMed
13.
go back to reference Rodríguez-Sanz A, Martínez-Sánchez P, Prefasi D, Fuentes B, Pascual-Salcedo D, Blanco-Bañares MJ et al (2014) Antiphospholipid antibodies correlate with stroke severity and outcome in patients with antiphospholipid syndrome. Autoimmunity 1:1–7 Rodríguez-Sanz A, Martínez-Sánchez P, Prefasi D, Fuentes B, Pascual-Salcedo D, Blanco-Bañares MJ et al (2014) Antiphospholipid antibodies correlate with stroke severity and outcome in patients with antiphospholipid syndrome. Autoimmunity 1:1–7
14.
go back to reference Verro P, Levine SR, Tietjen GE (1998) Cerebrovascular ischemic events with high positive anticardiolipin antibodies. Stroke 29:2245–2253CrossRefPubMed Verro P, Levine SR, Tietjen GE (1998) Cerebrovascular ischemic events with high positive anticardiolipin antibodies. Stroke 29:2245–2253CrossRefPubMed
15.
go back to reference Petty GW, Brown RD, Whisnant JP, Sicks JD, O’Fallon WM, Wiebers DO (2000) Ischemic stroke subtypes. A population-based study of functional outcome, survival, and recurrence. Stroke 31:1062–1068CrossRefPubMed Petty GW, Brown RD, Whisnant JP, Sicks JD, O’Fallon WM, Wiebers DO (2000) Ischemic stroke subtypes. A population-based study of functional outcome, survival, and recurrence. Stroke 31:1062–1068CrossRefPubMed
16.
go back to reference Gattellari M, Goumas C, Aitken R, Worthington JM (2011) Outcomes for patients with ischaemic stroke and atrial fibrillation: the PRISM study (A Program of Research Informing Stroke Management). Cerebrovasc Dis 32:370–382CrossRefPubMed Gattellari M, Goumas C, Aitken R, Worthington JM (2011) Outcomes for patients with ischaemic stroke and atrial fibrillation: the PRISM study (A Program of Research Informing Stroke Management). Cerebrovasc Dis 32:370–382CrossRefPubMed
17.
go back to reference Jørgensen HS, Nakayama H, Reith J, Raaschou HO, Olsen TS (1996) Acute stroke with atrial fibrillation. The Copenhagen stroke study. Stroke 27:1765–1769CrossRefPubMed Jørgensen HS, Nakayama H, Reith J, Raaschou HO, Olsen TS (1996) Acute stroke with atrial fibrillation. The Copenhagen stroke study. Stroke 27:1765–1769CrossRefPubMed
18.
go back to reference Seet RC, Zhang Y, Wijdicks EF, Rabinstein AA (2011) Relationship between chronic atrial fibrillation and worse outcomes in stroke patients after intravenous thrombolysis. Arch Neurol 11:1454–1558CrossRef Seet RC, Zhang Y, Wijdicks EF, Rabinstein AA (2011) Relationship between chronic atrial fibrillation and worse outcomes in stroke patients after intravenous thrombolysis. Arch Neurol 11:1454–1558CrossRef
19.
go back to reference Spengos K, Vemmos KN (2010) Etiology and outcome of cardioembolic stroke in young adults in Greece. Hellenic J Cardiol 51:127–132PubMed Spengos K, Vemmos KN (2010) Etiology and outcome of cardioembolic stroke in young adults in Greece. Hellenic J Cardiol 51:127–132PubMed
20.
go back to reference Murat Sumer M, Erturk O (2002) Ischemic stroke subtypes: risk factors, functional outcome and recurrence. Neurol Sci 22:449–454CrossRefPubMed Murat Sumer M, Erturk O (2002) Ischemic stroke subtypes: risk factors, functional outcome and recurrence. Neurol Sci 22:449–454CrossRefPubMed
21.
go back to reference Nam HS, Kim HC, Kim YD, Lee HS, Kim J, Lee DH (2012) Long-term mortality in patients with stroke of undetermined etiology. Stroke 43:2948–2956CrossRefPubMed Nam HS, Kim HC, Kim YD, Lee HS, Kim J, Lee DH (2012) Long-term mortality in patients with stroke of undetermined etiology. Stroke 43:2948–2956CrossRefPubMed
22.
23.
go back to reference Bamford J, Sandercock P, Dennis M, Burn J, Warlow C (1991) Classification and natural history of clinically identificable subtypes of cerebral infarction. Lancet 337:1521–1526CrossRefPubMed Bamford J, Sandercock P, Dennis M, Burn J, Warlow C (1991) Classification and natural history of clinically identificable subtypes of cerebral infarction. Lancet 337:1521–1526CrossRefPubMed
24.
go back to reference Clavier I, Hommel M, Besson G, Noèlle B, Ferjus Perret JL (1994) Long-term prognosis of symptomatic lacunar infarcts: a hospital-based study. Stroke 25:2005–2009CrossRefPubMed Clavier I, Hommel M, Besson G, Noèlle B, Ferjus Perret JL (1994) Long-term prognosis of symptomatic lacunar infarcts: a hospital-based study. Stroke 25:2005–2009CrossRefPubMed
25.
go back to reference Samuelsson M, Lindell D, Norrving B (1996) Presumed pathogenic mechanisms of recurrent stroke after lacunar infarction. Cerebrovascular Dis 27:661–666 Samuelsson M, Lindell D, Norrving B (1996) Presumed pathogenic mechanisms of recurrent stroke after lacunar infarction. Cerebrovascular Dis 27:661–666
26.
go back to reference Giroud M, Gras P, Milan C, Arveux P, Beuriat P, Vion P et al (1991) Natural history of lacunar síndromes. Contribution of the Dijon registry of cerebrovascular complications. Revue Neurol (Paris) 147:566–572 Giroud M, Gras P, Milan C, Arveux P, Beuriat P, Vion P et al (1991) Natural history of lacunar síndromes. Contribution of the Dijon registry of cerebrovascular complications. Revue Neurol (Paris) 147:566–572
27.
go back to reference Samuelsson M, Söderfelt B, Olsson GB (1996) Functional outcome in patients with lacunar infarction. Stroke 27:842–846CrossRefPubMed Samuelsson M, Söderfelt B, Olsson GB (1996) Functional outcome in patients with lacunar infarction. Stroke 27:842–846CrossRefPubMed
28.
go back to reference Lee VH, Brown RD Jr, Mandrekar JN, Mokri B (2006) Incidence and outcome of cervical artery dissection. A population-based study. Neurology 67:1809–1812CrossRefPubMed Lee VH, Brown RD Jr, Mandrekar JN, Mokri B (2006) Incidence and outcome of cervical artery dissection. A population-based study. Neurology 67:1809–1812CrossRefPubMed
29.
go back to reference Debette S, Leys D (2009) Cervical artery dissection: predisponing factors, diagnosis and outcome. Lancet Neurol 8:668–678CrossRefPubMed Debette S, Leys D (2009) Cervical artery dissection: predisponing factors, diagnosis and outcome. Lancet Neurol 8:668–678CrossRefPubMed
30.
go back to reference Kremer C, Mosso M, Georgiadis S, Benninger D, Arnold M, Baumgartner E (2003) Carotid dissection with permanent and transient occlusion or severe stenosis. Long-term outcome. Neurology 60:271–275CrossRefPubMed Kremer C, Mosso M, Georgiadis S, Benninger D, Arnold M, Baumgartner E (2003) Carotid dissection with permanent and transient occlusion or severe stenosis. Long-term outcome. Neurology 60:271–275CrossRefPubMed
31.
go back to reference Dziewas R, Konrad C, Dräger B, Even S, Besselmann M, Lüdemann P et al (2003) Cervical artery dissection: clinical features, risk factors, therapy and outcome in 126 patients. J Neurol 250:1179–1184CrossRefPubMed Dziewas R, Konrad C, Dräger B, Even S, Besselmann M, Lüdemann P et al (2003) Cervical artery dissection: clinical features, risk factors, therapy and outcome in 126 patients. J Neurol 250:1179–1184CrossRefPubMed
32.
go back to reference Bogousslavsky J, Despland PA, Regli F (1987) Spontaneuos carotid dissection with acute stroke. Arch Neurol 44:137–140CrossRefPubMed Bogousslavsky J, Despland PA, Regli F (1987) Spontaneuos carotid dissection with acute stroke. Arch Neurol 44:137–140CrossRefPubMed
33.
go back to reference Bassi P, Lattuada P, Gomitoni A (2003) Cervical cerebral artery dissection: a prospective study (preliminary report). Neurol Sci 24(supplement):s4–s7CrossRefPubMed Bassi P, Lattuada P, Gomitoni A (2003) Cervical cerebral artery dissection: a prospective study (preliminary report). Neurol Sci 24(supplement):s4–s7CrossRefPubMed
34.
go back to reference Putaala J, Curtze S, Hiltunen S, Tolppanen H, Tatlisumak T (2009) Causes of death and predictors of 5-year mortality in young adults after first-ever ischemic stroke: the Helsinki Young Stroke Registry. Stroke 40:2698–2703CrossRefPubMed Putaala J, Curtze S, Hiltunen S, Tolppanen H, Tatlisumak T (2009) Causes of death and predictors of 5-year mortality in young adults after first-ever ischemic stroke: the Helsinki Young Stroke Registry. Stroke 40:2698–2703CrossRefPubMed
35.
go back to reference Kappelle LJ, Adams HP, Heffner ML, Torner JC, Gomez F, Biller J (1994) Prognosis of young adults with ischemic stroke. A long-term follow-up study assessing recurrent vascular events and functional outcome in the Iowa Registry of stroke in young adults. Stroke 25:1360–1365CrossRefPubMed Kappelle LJ, Adams HP, Heffner ML, Torner JC, Gomez F, Biller J (1994) Prognosis of young adults with ischemic stroke. A long-term follow-up study assessing recurrent vascular events and functional outcome in the Iowa Registry of stroke in young adults. Stroke 25:1360–1365CrossRefPubMed
36.
go back to reference Fuentes B, Díez-Tejedor E, Ortega-Casarrubios MA, Martínez P, Lara M, Frank A (2006) Consistency of the benefits of stroke units over years of operation: an 8-year effectiveness analysis. Cerebrovasc Dis 21:173–179CrossRefPubMed Fuentes B, Díez-Tejedor E, Ortega-Casarrubios MA, Martínez P, Lara M, Frank A (2006) Consistency of the benefits of stroke units over years of operation: an 8-year effectiveness analysis. Cerebrovasc Dis 21:173–179CrossRefPubMed
37.
go back to reference Bogousslavsky J, van Melle G, Regli F (1988) The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke. Stroke 19:1083–1092CrossRefPubMed Bogousslavsky J, van Melle G, Regli F (1988) The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke. Stroke 19:1083–1092CrossRefPubMed
38.
go back to reference Arboix A, Alvarez-Sabin J, Soler L (1998) ad hoc editorial committee of the task force on cerebrovascular diseases of SEN: stroke: classification and diagnostic criteria. Neurología 13:3–10PubMed Arboix A, Alvarez-Sabin J, Soler L (1998) ad hoc editorial committee of the task force on cerebrovascular diseases of SEN: stroke: classification and diagnostic criteria. Neurología 13:3–10PubMed
39.
go back to reference Bogousslavsky J, Garazi S, Jeanrenaud X, Aebischer N, Van Melle G (1996) Stroke recurrence in patients with patent foramen ovale: the Lausanne Study. Neurology 46:1301–1305CrossRefPubMed Bogousslavsky J, Garazi S, Jeanrenaud X, Aebischer N, Van Melle G (1996) Stroke recurrence in patients with patent foramen ovale: the Lausanne Study. Neurology 46:1301–1305CrossRefPubMed
Metadata
Title
Severity and outcomes according to stroke etiology in patients under 50 years of age with ischemic stroke
Authors
Daniel Prefasi
Patricia Martínez-Sánchez
Blanca Fuentes
Exuperio Díez-Tejedor
Publication date
01-08-2016
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 2/2016
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-016-1336-5

Other articles of this Issue 2/2016

Journal of Thrombosis and Thrombolysis 2/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.